News from sorrento therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 30, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer

Sorrento Therapeutics, Inc. (Nasdaq: SRNE) announced today the appointment of George K. Ng to the position of Executive Vice President & Chief...

Mar 17, 2015, 07:20 ET

NantWorks et Sorrento annoncent une deuxième collaboration mondiale complète sur la découverte et le développement de nouvelles immunothérapies anticancéreuses

- NantCell acquiert les droits exclusifs d'anticorps comprenant les produits CAR-TNK™ et les inhibiteurs des points de contrôle PD-1 et...

Mar 17, 2015, 07:14 ET

NantWorks en Sorrento kondigen tweede brede wereldwijde samenwerking aan in de ontdekking en ontwikkeling van nieuwe immunotherapieën tegen kanker

- NantCell zal exclusieve rechten verwerven op antilichamen waaronder CAR-TNK™ Producten en de checkpointremmers PD-1 en PD-L1...

Mar 16, 2015, 13:56 ET

NantWorks und Sorrento kündigen ihre zweite, umfassende, weltweite Kooperation bei der Entdeckung und Entwicklung neuartiger Immunotherapien gegen Krebs an

- NantCell erwirbt die exklusiven Rechte an Antikörpern, wie den CAR-TNK™ Produkten und den Checkpoint-Inhibitoren PD-1 und PD-L1...

Mar 16, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

NantWorks And Sorrento Announce Second Comprehensive Global Collaboration On Discovery And Development Of Novel Anti-Cancer Immunotherapies

 NantWorks, Inc. and Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), announced today that they have entered into a...

Feb 23, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Sorrento to Present at Cowen and Company's 35th Annual Health Care Conference

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (Sorrento), an oncology company developing new treatments for cancer and associated...

Feb 05, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Sorrento to Present at the 17th Annual BIO CEO & Investor Conference

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated...

Feb 02, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Sorrento Announces Retention of Glen Sato to Provide Strategic Support

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced...

Jan 28, 2015, 14:41 ET

Sorrento kondigt afronding aan van deelname aan het Cynviloq™ TRIBECA™ registratieonderzoek

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), een oncologiebedrijf dat nieuwe behandelingen voor kanker en aanverwante pijn ontwikkelt,...

Jan 28, 2015, 12:00 ET

Sorrento annonce la fin du recrutement dans l'étude TRIBECA™ d'enregistrement Cynviloq™

Sorrento Therapeutics, Inc. (NASDAQ : SRNE ; Sorrento), la société d'oncologie qui développent de nouveaux traitements...

Jan 28, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Sorrento Announces Completion of Enrollment in the Cynviloq™ Registrational TRIBECA™ Study

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced today...

Jan 28, 2015, 09:00 ET

Sorrento gibt Ende der Rekrutierung für die Cynviloq™ TRIBECA™-Zulassungsstudie bekannt

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), ein Onkologieunternehmen, das neue Behandlungsmethoden für Krebs und damit verbundene...

Jan 12, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Sorrento Provides Status Update on the Cynviloq™ Registrational TRIBECA™ Study

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced...

Jan 06, 2015, 09:00 ET
Sorrento Therapeutics, Inc.

Conkwest, Sorrento And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and Conkwest, Inc., an...

Jan 05, 2015, 09:00 ET

Sorrento To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and...

Dec 24, 2014, 08:00 ET

Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board

 Conkwest, Inc., the Natural Killer Cell Company of the West, developing the proprietary Natural Killer (NK) cell-line platform,...

Dec 19, 2014, 06:00 ET

Sorrento and Conkwest Announce Exclusive Global Collaboration

 Sorrento Therapeutics, Inc. (NASDAQ: SRNE;  Sorrento), an oncology company developing new treatments for cancer and associated pain, and...

Dec 15, 2014, 09:25 ET

Sorrento Announces Strategic Investment By And Collaboration With Nantworks Founder Dr. Patrick Soon-Shiong For The Advancement Of Cancer Immunotherapies

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, announced today...

Dec 08, 2014, 09:15 ET

Sorrento Therapeutics Announces Poster Presentations on its Anti-c-Met/PD-L1 Bispecific Antibodies and Anti-c-Met-Antibody Drug Conjugate at the 37th Annual San Antonio Breast Cancer Symposium

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated...

Dec 03, 2014, 09:30 ET

Sorrento To Present At The 2014 Oppenheimer Healthcare Conference

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an oncology company developing new treatments for cancer and associated pain, today announced...